Skip to main content
. 2023 Oct 24;262(3):759–768. doi: 10.1007/s00417-023-06220-z

Table 2.

Clinical characteristics in each group of patients with diabetes

Severity of DR NDR NPDR PDR P value
Number of patients 30 24 29
Age (years) 58.0 ± 9.4 59.7 ± 7.3 56.4 ± 9.0 0.46
Sex (M/F) 20/10 14/10 16/13 0.64
HbA1c (%) 7.04 ± 0.98 7.65 ± 1.47 7.73 ± 1.84 0.28
HbA1c (mmol/mol) 53.4 ± 10.6 60.1 ± 16.1 61.0 ± 20.1 0.28
BMI (kg/m2) 26.5 ± 4.0 26.2 ± 5.5 26.5 ± 4.4 0.77
SBP (mmHg) 127.0 ± 13.6 136.8 ± 24.2 139.4 ± 19.5 0.02
DBP (mmHg) 80.6 ± 12.0 82.0 ± 12.1 83.7 ± 12.5 0.64
HT (n, %) 18, 60.0 19, 79.2 22, 75.9 0.33
DL (n, %) 17, 56.7 17, 70.8 14, 48.3 0.25
Total cholesterol (mg/dl) 193.4 ± 28.9 187.4 ± 34.9 205.0 ± 64.6 0.74
HDL (mg/dl) 55.0 ± 15.9 51.9 ± 12.9 51.9 ± 12.3 0.58
LDL (mg/dl) 109.9 ± 26.2 102.0 ± 30.7 122.2 ± 49.9 0.42
TG (mg/dl) 165.9 ± 85.0 156.2 ± 112.8 143.0 ± 84.5 0.41
eGFR (ml/min/1.73 m2) 75.6 ± 22.7 63.6 ± 23.5 56.2 ± 24.9 0.004
Glaucoma (n, %) 1, 3.3 2, 8.3 3, 10.3 0.56
NC parameters
  Number 4.73 ± 1.36 4.33 ± 1.77 3.66 ± 1.44 0.02
  Length (µm) 1183 ± 556 546 ± 479 538 ± 384  < 0.001
  Width (µm) 28.7 ± 8.4 21.3 ± 7.6 20.3 ± 6.4  < 0.001
  Turbidity 0.449 ± 0.138 0.291 ± 0.157 0.308 ± 0.141  < 0.001

HbA1c, hemoglobin A1c; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HT, Hypertension; DL, Dyslipidemia; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride; eGFR, estimated glomerular filtration rate; NC, nailfold capillary; DR, diabetic retinopathy; NDR, non-diabetic retinopathy; NPDR, non-proliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy. Differences between groups were tested with the Kruskal-Wallis test. The chi-square test was used for frequency data on sex, HT, DL, and glaucoma. Differences were considered significant at the P < 0.05 level